Celera Official Says Decision on Split with ABI Could Come By End of Quarter | GenomeWeb
SAN FRANCISCO (GenomeWeb News) – It’s looking very likely that Applied Biosystems and Celera will be split into two independently operated companies, and an announcement about the restructuring could come by the end of the current quarter.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.